ADAMTS13, Recombinant-Krhn - Mechanism of Action, Indications, Dosage, and Adverse Drug Reactions
ADAMST13, recombinant-krhn, an enzyme replacement therapy, is used for treating congenital thrombotic thrombocytopenic purpura.
Dr. Varunbabu Aucha
